Allele-specific repression of lymphotoxin-α by activated B cell factor-1

Nature Genetics

Volumn 36, Issue 4, 2004, Pages 394-399

  Knight, Julian C ^a   Keating, Brendan J ^a   Kwiatkowski, Dominic P ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED B CELL FACTOR 1; LYMPHOTOXIN; REPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ALLELE; ALLELISM; ARTICLE; ASTHMA; B LYMPHOCYTE; CHROMATIN; GENE EXPRESSION; GENE LOCUS; GENE REPRESSION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HAPLOTYPE; HEART INFARCTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REPORTER GENE; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; CELL LINE, TRANSFORMED; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; HAPLOTYPES; HUMANS; LYMPHOTOXIN-ALPHA; PLASMIDS; PRECIPITIN TESTS;

EID: 1842483836     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng1331     Document Type: Article

References (30)

1. Paul, N.L. & Ruddle, N.H. Lymphotoxin. Annu. Rev. Immunol. 6, 407-438 (1988).
2. Roach, D.R. et al. Secreted lymphotoxin-alpha is essential for the control of an intracellular bacterial infection. J. Exp. Med. 193, 239-246 (2001).
3. Engwerda, C.R. et al. Locally up-regulated lymphotoxin alpha, not systemic tumor necrosis factor alpha, is the principle mediator of murine cerebral malaria. J. Exp. Med. 195, 1371-1377 (2002).
4. Ozaki, K. et al. Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction. Nat. Genet. 32, 650-654 (2002).
5. Albuquerque, R.V. et al. Association of polymorphisms within the tumour necrosis factor (TNF) genes and childhood asthma. Clin. Exp. Allergy 28, 578-584 (1998).
6. Moffatt, M.F. & Cookson, W.O. Tumour necrosis factor haplotypes and asthma. Hum. Mol. Genet. 6, 551-554 (1997).
7. Stuber, F., Petersen, M., Bokelmann, F. & Schade, U. A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis. Crit. Care Med. 24, 381-384 (1996).
8. Majetschak, M. et al. Relation of a TNF gene polymorphism to severe sepsis in trauma patients. Ann. Surg. 230, 207-214 (1999).
9. Demeter, J. et al. Polymorphism of the tumor necrosis factor-alpha and lymphotoxin-alpha genes in chronic lymphocytic leukaemia. Br. J. Haematol. 97, 107-112 (1997).
10. Shimura, T. et al. The study of tumor necrosis factor beta gene polymorphism in lung cancer patients. Cancer 73, 1184-1188 (1994).
11. Yamaguchi, E., Itoh, A., Hizawa, N. & Kawakami, Y. The gene polymorphism of tumor necrosis factor-beta, but not that of tumor necrosis factor-alpha, is associated with the prognosis of sarcoidosis. Chest 119, 753-761 (2001).
12. Badenhoop, K. et al. Tumor necrosis factor beta polymorphisms in Graves' disease. J. Clin. Endocrinol. Metab. 74, 287-291 (1992).
13. Messer, G. et al. Polymorphic structure of the tumor necrosis factor (TNF) locus: an Ncol polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production. J. Exp. Med. 173, 209-219 (1991).
14. Lee, S.H. et al. Decreased tumour necrosis factor-beta production in TNFB*2 homozygote: an important predisposing factor of lupus nephritis in Koreans. Lupus 6, 603-609 (1997).
15. Pociot, F. et al. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-alpha and TNF-beta by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur. J. Immunol. 23, 224-231 (1993).
16. Whichelow, C.E., Hitman, G.A., Raafat, I., Bottazzo, G.F. & Sachs, J.A. The effect of TNF*B gene polymorphism on TNF-alpha and -beta secretion levels in patients with insulin-dependent diabetes mellitus and healthy controls. Eur. J. Immunogenet. 23, 425-435 (1996).
17. Knight, J.C., Keating, B.J., Rockett, K.A. & Kwiatkowski, D.P. In vivo characterization of regulatory polymorphisms by allele-specific quantification of RNA polymerase loading. Nat. Genet. 33, 469-475 (2003).
18. Dang, C.V., Dolde, C., Gillison, M.L. & Kato, G.J. Discrimination between related DNA sites by a single amino acid residue of Myc-related basic-helix-loop-helix proteins. Proc. Natl. Acad. Sci. USA 89, 599-602 (1992).
19. Ephrussi, A., Church, G.M., Tonegawa, S. & Gilbert, W. B lineage-specific interactions of an immunoglobulin enhancer with cellular factors in vivo. Science 227, 134-140 (1985).
20. Massari, M.E. et al. Characterization of ABF-1, a novel basic helix-loop-helix transcription factor expressed in activated B lymphocytes. Mol. Cell. Biol. 18, 3130-3139 (1998).
21. Mermod, N., Williams, T.J. & Tjian, R. Enhancer binding factors AP-4 and AP-1 act in concert to activate SV40 late transcription in vitro. Nature 332, 557-561 (1988).
22. Shen, C.-P. & Kadesch, T. B-cell-specific DNA binding by an E47 homodimer. Mol. Cell. Biol. 15, 4518-4524 (1995).
23. Wong, J. et al. Characterization of a basic helix-loop-helix protein, ABF-1: nuclear localization, transcriptional properties, and interaction with Id-2. DNA Cell. Biol. 20, 465-471 (2001).
24. Gunning, P., Leavitt, J., Muscat, G., Ng, S.Y. & Kedes, L. A human beta-actin expression vector system directs high-level accumulation of antisense transcripts. Proc. Natl. Acad. Sci. USA 84, 4831-4835 (1987).
25. Aranburu, A., Carlsson, R., Persson, C. & Leanderson, T. Transcription factor AP-4 is a ligand for immunoglobulin-kappa promoter E-box elements. Biochem. J. 354, 431-438 (2001).
26. Schreiber, E., Matthias, P., Muller, M.M. & Schaffner, W. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res. 17, 6419 (1989).
27. Udalova, I.A., Knight, J.C., Vidal, V., Nedospasov, S.A. & Kwiatkowski, D. Complex NF-kappaB interactions at the distal tumor necrosis factor promoter region in human monocytes. J. Biol. Chem. 273, 21178-21186 (1998).
28. Ou, S.H., Garcia-Martinez, L.F., Paulssen, E.J. & Gaynor, R.B. Role of flanking E box motifs in human immunodeficiency virus type 1 TATA element function. J. Virol. 68, 7188-7199 (1994).
29. Nissen, R.M. & Yamamoto, K.R. The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain. Genes Dev. 14, 2314-2329 (2000).
30. Takahashi, Y., Rayman, J.B. & Dynlacht, B.D. Analysis of promoter binding by the E2F and pRB families in vivo: distinct E2F proteins mediate activation and repression. Genes Dev. 14, 804-816 (2000).